166 related articles for article (PubMed ID: 19967081)
1. Aureobasidium-derived soluble branched (1,3-1,6) beta-glucan (Sophy beta-glucan) enhances natural killer activity in Leishmania amazonensis-infected mice.
Yatawara L; Wickramasinghe S; Nagataki M; Takamoto M; Nomura H; Ikeue Y; Watanabe Y; Agatsuma T
Korean J Parasitol; 2009 Dec; 47(4):345-51. PubMed ID: 19967081
[TBL] [Abstract][Full Text] [Related]
2. Effects of water-soluble low-molecular-weight beta-1, 3-D-glucan (branch beta-1, 6) isolated from Aureobasidium pullulans 1A1 strain black yeast on restraint stress in mice.
Kimura Y; Sumiyoshi M; Suzuki T; Suzuki T; Sakanaka M
J Pharm Pharmacol; 2007 Aug; 59(8):1137-44. PubMed ID: 17725857
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
4. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis.
Afonso LC; Scott P
Infect Immun; 1993 Jul; 61(7):2952-9. PubMed ID: 8514400
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice.
Guimarães ET; Santos LA; Ribeiro dos Santos R; Teixeira MM; dos Santos WL; Soares MB
Microbes Infect; 2006 Apr; 8(5):1219-26. PubMed ID: 16531090
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.
Pinto EF; de Mello Cortezia M; Rossi-Bergmann B
Vaccine; 2003 Sep; 21(25-26):3534-41. PubMed ID: 12922080
[TBL] [Abstract][Full Text] [Related]
7. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis.
Padigel UM; Alexander J; Farrell JP
J Immunol; 2003 Oct; 171(7):3705-10. PubMed ID: 14500669
[TBL] [Abstract][Full Text] [Related]
8. Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.
Felizardo TC; Gaspar-Elsas MI; Lima GM; Abrahamsohn IA
Exp Parasitol; 2012 Jan; 130(1):48-57. PubMed ID: 22019418
[TBL] [Abstract][Full Text] [Related]
9. Experimental infection of Balb/c mice with Leishmania panamensis and Leishmania mexicana: induction of early IFN-gamma but not IL-4 is associated with the development of cutaneous lesions.
Guevara-Mendoza O; Une C; Franceschi Carreira P; Orn A
Scand J Immunol; 1997 Jul; 46(1):35-40. PubMed ID: 9246206
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.
Pratti JE; Ramos TD; Pereira JC; da Fonseca-Martins AM; Maciel-Oliveira D; Oliveira-Silva G; de Mello MF; Chaves SP; Gomes DC; Diaz BL; Rossi-Bergmann B; de Matos Guedes HL
Parasit Vectors; 2016 Oct; 9(1):534. PubMed ID: 27716449
[TBL] [Abstract][Full Text] [Related]
11. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
[TBL] [Abstract][Full Text] [Related]
13. The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy.
Pratti JES; da Fonseca Martins AM; da Silva JP; Ramos TD; Pereira JC; Firmino-Cruz L; Oliveira-Maciel D; Vieira TSS; Lacerda LL; Vale AM; Freire-de-Lima CG; Gomes DCO; Saraiva EM; Rossi-Bergmann B; de Matos Guedes HL
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007146. PubMed ID: 30802247
[TBL] [Abstract][Full Text] [Related]
14. β-Adrenergic blockade protects BALB/c mice against infection with a small inoculum of Leishmania mexicana mexicana (LV4).
García-Miss Mdel R; Mut-Martín MC; Góngora-Alfaro JL
Int Immunopharmacol; 2015 Jan; 24(1):59-67. PubMed ID: 25461918
[TBL] [Abstract][Full Text] [Related]
15. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.
Coelho EA; Tavares CA; Carvalho FA; Chaves KF; Teixeira KN; Rodrigues RC; Charest H; Matlashewski G; Gazzinelli RT; Fernandes AP
Infect Immun; 2003 Jul; 71(7):3988-94. PubMed ID: 12819086
[TBL] [Abstract][Full Text] [Related]
16. T cell response in murine Leishmania mexicana amazonensis infection: production of interferon-gamma by CD8+ cells.
Chan MM
Eur J Immunol; 1993 May; 23(5):1181-4. PubMed ID: 8097471
[TBL] [Abstract][Full Text] [Related]
17. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.
Jones DE; Buxbaum LU; Scott P
J Immunol; 2000 Jul; 165(1):364-72. PubMed ID: 10861073
[TBL] [Abstract][Full Text] [Related]
18. Short-term protection conferred by Leishvacin® against experimental Leishmania amazonensis infection in C57BL/6 mice.
Carneiro MB; de Andrade e Sousa LM; Vaz LG; Dos Santos LM; Vilela L; de Souza CC; Gonçalves R; Tafuri WL; Afonso LC; Côrtes DF; Vieira LQ
Parasitol Int; 2014 Dec; 63(6):826-34. PubMed ID: 25102355
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl/6 mice.
Pinheiro RO; Rossi-Bergmann B
Mem Inst Oswaldo Cruz; 2007 Feb; 102(1):79-82. PubMed ID: 17294004
[TBL] [Abstract][Full Text] [Related]
20. Immunological actions of Sophy beta-glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement.
Ikewaki N; Fujii N; Onaka T; Ikewaki S; Inoko H
Microbiol Immunol; 2007; 51(9):861-73. PubMed ID: 17895603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
